Clinical trial
Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast…
NCT00043017 · American College of Radiology Imaging Network, Other · Completed
Key facts
| NCT number | NCT00043017 |
|---|---|
| Title | Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer |
| Official title | Contrast-Enhanced Breast MRI For Evaluation Of Patients Undergoing Neoadjuvant Treatment For Locally-Advanced Breast Cancer (I-SPY 1/ACRIN 6657) |
| Acronym | ACRIN 6657 |
| Lead sponsor | American College of Radiology Imaging Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Procedure, Radiation |
| Interventions | MRI/MRS, gadopentetate dimeglumine |
| Enrollment | 356 |
| Start date | May 1, 2002 |
| Primary completion | May 1, 2005 |
| Completion | Mar 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 9, 2013 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: